Papers

Sep, 2008

AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects

Diabetes research and clinical practice.
  • K.Konishi
  • ,
  • S.Nakano
  • ,
  • S.Tsuda
  • ,
  • A.Nakagawa
  • ,
  • T.Kigoshi
  • ,
  • D.Koya

Volume
81:310-315
Number
Language
English
Publishing type
Research paper (international conference proceedings)

ID information
  • ISSN : 0168-8227

Export
BibTeX RIS